Published in Eur J Biochem on October 01, 2000
TAT peptide on the surface of liposomes affords their efficient intracellular delivery even at low temperature and in the presence of metabolic inhibitors. Proc Natl Acad Sci U S A (2001) 3.06
Cell-penetrating peptides and antimicrobial peptides: how different are they? Biochem J (2006) 1.92
Cellular uptake of Antennapedia Penetratin peptides is a two-step process in which phase transfer precedes a tryptophan-dependent translocation. Nucleic Acids Res (2003) 1.04
Cell-penetrating peptides: achievements and challenges in application for cancer treatment. J Biomed Mater Res A (2013) 0.90
Passage of cell-penetrating peptides across a human epithelial cell layer in vitro. Biochem J (2004) 0.89
Nuclear localization of cell-penetrating peptides is dependent on endocytosis rather than cytosolic delivery in CHO cells. Mol Pharm (2009) 0.85
The Role of Cell-Penetrating Peptide and Transferrin on Enhanced Delivery of Drug to Brain. Int J Mol Sci (2016) 0.78
Effects of redox state on the efficient uptake of cell permeable Peptide in Mammalian cells. Open Biochem J (2013) 0.75
Peptide helicity and membrane surface charge modulate the balance of electrostatic and hydrophobic interactions with lipid bilayers and biological membranes. Biochemistry (1996) 1.71
Optimization of the antimicrobial activity of magainin peptides by modification of charge. FEBS Lett (2001) 1.52
Hydrophobicity, hydrophobic moment and angle subtended by charged residues modulate antibacterial and haemolytic activity of amphipathic helical peptides. FEBS Lett (1997) 1.47
Protein kinase A anchoring proteins are required for vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J Biol Chem (1999) 1.45
Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation. J Neurochem (2002) 1.40
A dileucine sequence and an upstream glutamate residue in the intracellular carboxyl terminus of the vasopressin V2 receptor are essential for cell surface transport in COS.M6 cells. Mol Pharmacol (1998) 1.34
Peptide hydrophobicity controls the activity and selectivity of magainin 2 amide in interaction with membranes. Biochemistry (1997) 1.29
Phosphopeptide analysis by positive and negative ion matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun Mass Spectrom (2001) 1.25
Cellular uptake of an alpha-helical amphipathic model peptide with the potential to deliver polar compounds into the cell interior non-endocytically. Biochim Biophys Acta (1998) 1.23
An inhibitory role of Rho in the vasopressin-mediated translocation of aquaporin-2 into cell membranes of renal principal cells. J Biol Chem (2001) 1.20
The tendency of magainin to associate upon binding to phospholipid bilayers. Biochemistry (1997) 1.13
Modulation of membrane activity of amphipathic, antibacterial peptides by slight modifications of the hydrophobic moment. FEBS Lett (1997) 1.11
Influence of the angle subtended by the positively charged helix face on the membrane activity of amphipathic, antibacterial peptides. Biochemistry (1997) 1.09
Comparison of the effects of 5- and 6-HOAt on model peptide coupling reactions relative to the cases for the 4- and 7-Isomers. Org Lett (2000) 1.04
Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma. Leukemia (2008) 1.03
Location of an amphipathic alpha-helix in peptides using reversed-phase HPLC retention behavior of D-amino acid analogs. Anal Chem (1995) 1.02
A role for a helical connector between two receptor binding sites of a long-chain peptide hormone. J Biol Chem (2000) 0.99
Achieving signalling selectivity of ligands for the corticotropin-releasing factor type 1 receptor by modifying the agonist's signalling domain. Br J Pharmacol (2007) 0.99
Conformational and functional study of magainin 2 in model membrane environments using the new approach of systematic double-D-amino acid replacement. Biochemistry (1996) 0.98
Structural requirements for cellular uptake of alpha-helical amphipathic peptides. J Pept Sci (1999) 0.98
Late endosomal/lysosomal targeting and lack of recycling of the ligand-occupied endothelin B receptor. Mol Pharmacol (2000) 0.97
Mechanism of peptide-induced mast cell degranulation. Translocation and patch-clamp studies. J Gen Physiol (1998) 0.97
Study of the conformational transition of A beta(1-42) using D-amino acid replacement analogues. Biochemistry (2001) 0.96
Antimicrobial activity of arginine- and tryptophan-rich hexapeptides: the effects of aromatic clusters, D-amino acid substitution and cyclization. J Pept Res (2004) 0.95
Folding and cell surface expression of the vasopressin V2 receptor: requirement of the intracellular C-terminus. FEBS Lett (1998) 0.95
Evidence that corticotropin-releasing factor receptor type 1 couples to Gs- and Gi-proteins through different conformations of its J-domain. Br J Pharmacol (2006) 0.95
Mast cell activation--a receptor-independent mode of substance P action? FEBS Lett (1987) 0.93
A single-point slight alteration set as a tool for structure-activity relationship studies of ovine corticotropin releasing factor. J Med Chem (1996) 0.91
[Nphe(1)]NC(1-13)NH(2) selectively antagonizes nociceptin/orphanin FQ-stimulated G-protein activation in rat brain. J Pharmacol Exp Ther (2000) 0.90
Cell volume kinetics of adherent epithelial cells measured by laser scanning reflection microscopy: determination of water permeability changes of renal principal cells. Biophys J (2001) 0.90
[Bronchological diagnosis of sarcoidosis]. Bronches (1974) 0.89
Histamine release induced by Arg-Pro-Lys-Pro(CH2)11CH3 from rat peritoneal mast cells. J Pharmacol Exp Ther (1987) 0.88
Proline at position 14 of alamethicin is essential for hemolytic activity, catecholamine secretion from chromaffin cells and enhanced metabolic activity in endothelial cells. Biochim Biophys Acta (1998) 0.87
Relaxing actions of corticotropin-releasing factor on rat resistance arteries. Br J Pharmacol (1993) 0.87
Distinct molecular recognition of calmodulin-binding sites in the neuronal and macrophage nitric oxide synthases: a surface plasmon resonance study. Biochemistry (1996) 0.87
Evaluation of cotton as a carrier for solid-phase peptide synthesis. Pept Res (1992) 0.87
Temperature coefficients of amide proton NMR resonance frequencies in trifluoroethanol: a monitor of intramolecular hydrogen bonds in helical peptides. J Biomol NMR (1996) 0.85
Influence of proline position upon the ion channel activity of alamethicin. Biophys J (1997) 0.85
Polarized cell surface expression of the green fluorescent protein-tagged vasopressin V2 receptor in Madin Darby canine kidney cells. FEBS Lett (1998) 0.84
Self-association of the neuroregulatory peptide substance P and Its C-terminal sequences. Biopolymers (1984) 0.83
p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer. Br J Cancer (1999) 0.83
MALDI-MS for C-terminal sequence determination of peptides and proteins degraded by carboxypeptidase Y and P. FEBS Lett (1995) 0.82
Isolation, structural characterization, and bioactivity of a novel neuromedin U analog from the defensive skin secretion of the Australasian tree frog, Litoria caerulea. J Biol Chem (2000) 0.82
Corticotropin-releasing hormone (CRH) receptors in the mesenteric small arteries of rats resemble the (2)-subtype. Biochem Pharmacol (1996) 0.82
Extensive cellular uptake into endothelial cells of an amphipathic beta-sheet forming peptide. FEBS Lett (1997) 0.82
Conformation of a water-soluble beta-sheet model peptide. A circular dichroism and Fourier-transform infrared spectroscopic study of double D-amino acid replacements. Int J Pept Protein Res (1996) 0.82
Water-soluble beta-sheet models which self-assemble into fibrillar structures. Biochemistry (1999) 0.81
Circular dichroism studies of substance P and its C-terminal sequences. CD spectra in aqueous solution and effects of hydrogen ion concentration. Int J Pept Protein Res (1980) 0.81
The nociceptin/orphanin FQ receptor ligand acetyl-RYYRIK-amide exhibits antagonistic and agonistic properties. Peptides (2000) 0.81
Effects of kinins on mammalian spermatozoa and the impact of peptidolytic enzymes. Andrologia (2003) 0.81
Functional modifications of alamethicin ion channels by substitution of glutamine 7, glycine 11 and proline 14. Biochim Biophys Acta (1998) 0.81
Antagonism by acetyl-RYYRIK-NH2 of G protein activation in rat brain preparations and of chronotropic effect on rat cardiomyocytes evoked by nociceptin/orphanin FQ. Br J Pharmacol (1999) 0.81
Cellular uptake of antisense oligonucleotides after complexing or conjugation with cell-penetrating model peptides. Eur J Biochem (2002) 0.80
The essential sequence of substance P for locomotion. Pharmazie (1986) 0.80
Peptide destabilization by two adjacent D-amino acids in single-stranded amphipathic alpha-helices. Pept Res (1997) 0.80
Structure effects of double D-amino acid replacements: a nuclear magnetic resonance and circular dichroism study using amphipathic model helices. Biochemistry (1995) 0.80
Circular dichroism and infrared studies of substance P and C-terminal analogs. Biochem Biophys Res Commun (1975) 0.80
Noncovalent immobilized artificial membrane chromatography, an improved method for describing peptide-lipid bilayer interactions. J Chromatogr A (1999) 0.79
Recognition of alpha-helical peptide structures using high-performance liquid chromatographic retention data for D-amino acid analogues: influence of peptide amphipathicity and of stationary phase hydrophobicity. J Chromatogr A (1995) 0.79
Role of helix formation for the retention of peptides in reversed-phase high-performance liquid chromatography. J Chromatogr A (2001) 0.79
Evidence for downregulation of the endothelin-B-receptor by the use of fluorescent endothelin-1 and a fusion protein consisting of the endothelin-B-receptor and the green fluorescent protein. J Cardiovasc Pharmacol (2000) 0.78
Modulation of locomotor activity by substance P in rats. Regul Pept (1983) 0.78
Astrocytes induce manganese superoxide dismutase in brain capillary endothelial cells. Neuroreport (2001) 0.78
[Studies on the mechanism of action of peptide attacking smooth muscle. II. Differentiation of biologic activity of tachykinins in affinity and intrinsic efficacy]. Acta Biol Med Ger (1975) 0.77
Gonadotropin-releasing hormone (GnRH) analogs: relationship between their structure, proteolytic inactivation and pharmacokinetics in rats. Regul Pept (1991) 0.77
Energy metabolism and intracellular pH in boar spermatozoa. Reproduction (2003) 0.77
Polarized expression of the vasopressin V2 receptor in Madin-Darby canine kidney cells. Kidney Int (1999) 0.77
[Differential value of various vital stains of corneal endothelium]. Ophthalmologe (1995) 0.77
[Color Doppler sonography of retrobulbar vessels and hypercapnia in normal tension glaucoma]. Ophthalmologe (2012) 0.77
Spontaneous chemical degradation of substance P in the solid phase and in solution. Int J Pept Protein Res (1993) 0.77
Long-term morphine treatment increases Ku protein DNA end-binding activity. Neuroreport (1997) 0.76
Effect of substance P on mechanical and myoelectrical activities of stomach and small intestines in conscious dog. Arch Int Pharmacodyn Ther (1978) 0.76
Influence of alpha-helicity, amphipathicity and D-amino acid incorporation on the peptide-induced mast cell activation. Eur J Pharmacol (1995) 0.76
Synthesis, photochemistry and application of (7-methoxycoumarin-4-yl)methyl-caged 8-bromoadenosine cyclic 3',5'-monophosphate and 8-bromoguanosine cyclic 3',5'-monophosphate photolyzed in the nanosecond time region. J Photochem Photobiol B (2000) 0.76
Evidence for extensive and non-specific translocation of oligopeptides across plasma membranes of mammalian cells. Biochim Biophys Acta (1997) 0.76
Some observations indicating a low brain uptake of [3H]Nle11-Substance P. Pharmazie (1983) 0.76
Peptide leucine arginine, a potent immunomodulatory peptide isolated and structurally characterized from the skin of the Northern Leopard frog, Rana pipiens. J Biol Chem (2000) 0.76
Conformational differences of ovine and human corticotropin releasing hormone. A CD, IR, NMR and dynamic light scattering study. Int J Pept Protein Res (1996) 0.76
Hydrophobically induced conformation in ovine corticotropin-releasing hormone. J Pept Res (1997) 0.76
Neuropeptide Y-induced mast cell activation. Biochem Soc Trans (1994) 0.76
Protective effects of the thiophosphate amifostine (WR 2721) and a lazaroid (U83836E) on lipid peroxidation in endothelial cells during hypoxia/reoxygenation. Biochem Pharmacol (1998) 0.76
Structure activity studies of mast cell activation and hypotension induced by neuropeptide Y (NPY), centrally truncated and C-terminal NPY analogues. Br J Pharmacol (1996) 0.75
p53 mutations and codon 213 polymorphism of p53 in lung cancers of former uranium miners. J Cancer Res Clin Oncol (1999) 0.75
Disposition of the 3H-labeled gonadotropin-releasing hormone analog buserelin in rats. Drug Metab Dispos (1993) 0.75
[Experimental and clinical experiences with bronchologic lasers]. Z Erkr Atmungsorgane (1987) 0.75
[Our indications for tracheostomy and plastic closure of the tracheostoma. analysis of case reports. IInd communication]. Z Erkr Atmungsorgane (1975) 0.75
[Cystic fibrotic lung changes with aspergilloma in ankylosing spondylitis]. Prax Klin Pneumol (1988) 0.75